antiretrovirals

Identity
The FDA Has Approved Generic PrEP—but Access May Remain Difficult
Experts cited complicated factors, like patient and doctor awareness and the unique way the US HIV medication market functions, as reasons not to get your hopes up.
Keren Landman
6.15.17
Identity
My First 30 Years with HIV
French HIV/AIDS activist Didier Lestrade reflects on a lifetime spent fighting the epidemic, in both public and private.
Didier Lestrade
2.23.17
Tech
A Successful New HIV-Nuking Drug Wasn't Even Designed for HIV
It may even be part of an eventual HIV cure.
Michael Byrne
5.19.16